Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Melanoma 5 Colitis 4 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Vasculitis 1 Stroke 1 Skin Neoplasms 1 Lung Neoplasms 1 Kidney Transplantation 1 Hepatitis 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Drug-Related Side Effects and Adverse Reactions 1 Depressive Disorder, Treatment-Resistant 1 Depressive Disorder, Major 1 Depression 1 Colitis, Ulcerative 1 Bronchiolitis Obliterans Syndrome 1 Bipolar Disorder 1 Aneurysm 1

Interventions

Specimen Handling 2 Nivolumab 2 Educational Status 2 pembrolizumab 1 cabozantinib 1 Standard of Care 1 Practice Guidelines as Topic 1 Platinum Compounds 1 NX-13 1 Methods 1 Ipilimumab 1 Interviews as Topic 1 Infliximab 1 Early Intervention, Educational 1 Colonoscopy 1 CTLA-4 Antigen 1 Biopsy 1 Atorvastatin 1 ABX464 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis, Ulcerative × Infliximab × 1 year × Clear all

NCT03765450 2026-06-02

PROTOS

Alimentiv Inc.

Active not recruiting

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡